Trevi Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Trevi Therapeutics's estimated annual revenue is currently $4.5M per year.
- Trevi Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Trevi Therapeutics has 29 Employees.
- Trevi Therapeutics grew their employee count by -22% last year.
Trevi Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, President and CEO | Reveal Email/Phone |
2 | VP, Global Regulatory Affairs | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | VP Clinical Development | Reveal Email/Phone |
5 | Co-Founder, Chief Science Officer | Reveal Email/Phone |
6 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | Associate Director, Quality Assurance & Compliance | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Senior Director, Technical Operations | Reveal Email/Phone |
Trevi Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.2M | 1 | -80% | N/A | N/A |
#2 | $4.3M | 28 | 8% | N/A | N/A |
#3 | $9.8M | 66 | -11% | N/A | N/A |
#4 | $1.4M | 9 | 350% | N/A | N/A |
#5 | $16.6M | 107 | -23% | N/A | N/A |
#6 | $4.5M | 29 | -22% | N/A | N/A |
#7 | $1.7M | 11 | 57% | N/A | N/A |
#8 | $2.3M | 15 | -6% | N/A | N/A |
#9 | $0.3M | 4 | -43% | N/A | N/A |
#10 | $4M | 26 | 0% | N/A | N/A |
What Is Trevi Therapeutics?
Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease. The conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Founded in 2011, Trevi is headquartered in New Haven, CT.
keywords:N/A
N/A
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Trevi Therapeutics News
Trevi Therapeutics Inc's score of 100 means that it ranks higher than 100% of stocks in the sector. In addition, its overall score of 81 ranks...
Trevi Therapeutics to Participate at 21st Annual Needham Virtual Healthcare Conference. Trevi Therapeutics, Inc. www.trevitherapeutics.com (...
NEW HAVEN, Conn., April 7, 2022 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company...
Other Companies in New Haven
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.6M | 29 | 12% | N/A |
#2 | $5.9M | 29 | -24% | N/A |
#3 | $2.8M | 29 | -6% | N/A |
#4 | $15M | 29 | 4% | N/A |
#5 | N/A | 29 | 32% | N/A |